Deputy Editor

Dr. Kamath is a GI medical oncologist at Cleveland Clinic Cancer Center and an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He earned his medical degree from Columbia University College of Physicians & Surgeons, New York, NY. He completed his internal medicine residency, along with his fellowship in Hematology/Oncology at Northwestern University Feinberg School of Medicine, Chicago, IL. He is an American Society of Clinical Oncology (ASCO) Ambassador and a member of the ASCO Multi-Site Guideline Advisory Group. Dr. Kamath is a member of the Center for Young-Onset Colorectal Cancer at Cleveland Clinic. He is an academic clinical investigator in the area of gastrointestinal malignancies.
Guardant Health; Takeda; Pfizer; SirTex; BeiGene; Jazz Pharmaceuticals; Exelixis
BeiGene; AstraZeneca; Pfizer; Merck; Takeda
Cancer Medicine